Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker NKTR
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2026 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 1, 2026 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 25, 2026 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 8, 2026 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2026 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 5, 2026 | NKTR Nektar Therapeutics | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 8, 2026 | NKTR Nektar Therapeutics | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 8, 2026 | NKTR Nektar Therapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 7, 2026 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 23, 2026 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 23, 2026 | NKTR Nektar Therapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 20, 2026 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 20, 2026 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 20, 2026 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 12, 2026 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 13, 2026 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 13, 2026 | NKTR Nektar Therapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 10, 2026 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 10, 2026 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 10, 2026 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 27, 2026 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 16, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 16, 2025 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 21, 2025 | NKTR Nektar Therapeutics | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 10, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 10, 2025 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 6, 2025 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 18, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 18, 2025 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 7, 2025 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 1, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 1, 2025 | NKTR Nektar Therapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 27, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 24, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 24, 2025 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 6, 2025 | NKTR Nektar Therapeutics | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jun 4, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| May 28, 2025 | NKTR Nektar Therapeutics | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 8, 2025 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 4, 2025 | NKTR Nektar Therapeutics | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Mar 28, 2025 | NKTR Nektar Therapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 12, 2025 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 24, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 4, 2025 | NKTR Nektar Therapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 2, 2024 | NKTR Nektar Therapeutics | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Nov 7, 2024 | NKTR Nektar Therapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 4, 2024 | NKTR Nektar Therapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2024 | NKTR Nektar Therapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
49 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:13 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances